5/12/2020 4:15:30 PM
Danaher Announces Closing Of Common Stock Offering
5/8/2020 1:18:53 AM
Danaher Prices Offerings Of 9.51 Mln Shares At $163/Shr And 1.55 Mln Shares Of 5.00% Series B Preferred Stock
5/7/2020 8:44:09 AM
Danaher Begins Concurrent Offerings Of $1.25 Bln Of Common Stock And $1.25 Bln Of Shares Of Preferred Stock
5/6/2020 4:12:27 PM
Danaher Q1 EPS $0.81 Vs $0.45 Last Year; Names Rainer Blair To Succeed Thomas Joyce As President And CEO
5/5/2020 4:12:46 PM
Danaher Corp. (DHR) Declares Quarterly Dividend of $ 0.18, Record Date 6/26/2020
4/30/2020 9:05:06 AM
Danaher Completes Sale Of Certain Businesses To Sartorius AG To Satisfy Regulatory Requirement For Cytiva Acquisition
4/13/2020 6:52:49 AM
Danaher Expects Q1 Revenue Growth Of 3.0% And Non-GAAP Core Revenue Growth Of 4.5%; Withdraws 2020 Guidance
3/31/2020 6:10:15 PM
Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences
3/21/2020 9:03:45 AM
Cepheid Receives Emergency Use Authorization From FDA For Rapid SARS-CoV-2 Test
2/20/2020 4:22:29 PM
Danaher Approves Quarterly Dividend Of $0.18/shr, Payable April 24/record March 27
2/20/2020 4:19:50 PM
Danaher Corp. (DHR) Declares Quarterly Dividend of $ 0.18, Record Date 3/27/2020
1/30/2020 6:02:40 AM
Danaher Q4 EPS From Cont Ops $1.07 Vs $0.96 Last Year